glp 1 def GLP-1 for Weight Loss and Diabetes GLP-1 and Health: Beyond Weight

Pharmacological strategies to retard cardiovascular aging

Hazard ratios (HRs) with 95% confidence intervals (CIs) were used to assess primary (MACE) and secondary outcomes (all-cause mortality, CV death, non-fatal MI, non-fatal stroke, and HF hospitalisation) between the two treatment groups

Metabolic dysfunction-associated steatotic liver disease and pregnancy

Anti-obesity and glucose-lowering pharmacotherapies predominantly exert their actions by inducing satiety (liraglutide, setmelanotide, lorcaserin, pramlintide, sibutramine) or by inducing malabsorption of nutrients (orlistat)

If you are considering IV therapy at NuLife Health, we encourage you to schedule a consultation with our qualified healthcare providers

& Vilchis, L